Filing Details

Accession Number:
0001209191-20-050592
Form Type:
4
Zero Holdings:
No
Publication Time:
2020-09-15 19:23:53
Reporting Period:
2020-09-14
Accepted Time:
2020-09-15 19:23:53
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1422143 Kura Oncology Inc. KURA Pharmaceutical Preparations (2834) 611547851
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1748894 Marc Grasso C/O Kura Oncology, Inc.
12730 High Bluff Drive, Suite 400
San Diego CA 92130
Cfo, Cbo No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2020-09-14 7,898 $29.00 7,898 No 4 M Direct
Common Stock Acquisiton 2020-09-14 2,102 $29.00 10,000 No 4 M Direct
Common Stock Disposition 2020-09-14 10,000 $29.00 0 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Option to purchase common stock Disposition 2020-09-14 7,898 $0.00 7,898 $15.47
Common Stock Option to purchase common stock Disposition 2020-09-14 2,102 $0.00 2,102 $19.40
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
105,000 2029-01-21 No 4 M Direct
247,898 2028-08-20 No 4 M Direct
Footnotes
  1. The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 21, 2019.
  2. This option vests in 48 equal monthly installments commencing on January 22, 2019.
  3. This option vests in 48 equal monthly installments commencing on August 21, 2018.